Smith Group Asset Management’s Omega Protein OME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-120,160
Closed -$2.15M 489
2017
Q2
$2.15M Sell
120,160
-1,410
-1% -$26.3K 0.07% 152
2017
Q1
$2.44M Sell
121,570
-1,040
-0.8% -$24.2K 0.07% 153
2016
Q4
$3.07M Buy
122,610
+39,660
+48% +$937K 0.09% 129
2016
Q3
$1.94M Buy
+82,950
New +$1.95M 0.06% 147
2014
Q3
Sell
-228,370
Closed -$3.12M 445
2014
Q2
$3.12M Sell
228,370
-10,900
-5% -$142K 0.12% 139
2014
Q1
$2.89M Sell
239,270
-2,416
-1% -$27.7K 0.11% 146
2013
Q4
$2.97M Buy
+241,686
New +$2.84M 0.11% 146
2013
Q3
Sell
-2,168
Closed -$19K 453
2013
Q2
$19K Buy
+2,168
New +$21.8K ﹤0.01% 300

Other funds holding OME

Smith Group Asset Management's OME Position: Q3 2017 in Review

Smith Group Asset Management sold out of Omega Protein (OME) in Q3 2017, closing a stake of 120,160 shares — an estimated $2.15M sold.

Smith Group Asset Management first reported a position in OME in Q2 2013 and held it in 8 quarters. The position peaked at $3.12M in Q2 2014. 122 funds tracked by Wall St. Rank hold OME as of Q3 2017.

  • Smith Group Asset Management reported no remaining Omega Protein position as of Q3 2017 after selling out during the quarter.
  • Smith Group Asset Management sold 120,160 Omega Protein shares in Q3 2017, an estimated $2.15M.
  • Smith Group Asset Management first reported a position in Omega Protein in Q2 2013 and held it in 8 quarters.
  • Smith Group Asset Management's Omega Protein position peaked at $3.12M in Q2 2014.
  • 122 funds tracked by Wall St. Rank held Omega Protein as of Q3 2017.

Based on Smith Group Asset Management's 13F filing for Q3 2017, filed 2 Nov 2017.